Novel Nonhormonal Drug Approved for Menopause Hot Flashes

(MedPage Today) — The FDA has approved elinzanetant (Lynkuet), a new type of non-hormonal drug intended to treat disruptive menopausal hot flashes, Bayer announced Friday. Elinzanetant is now the first and only dual neurokinin (NK) targeted therapy -…